125 / 490
123
SCIENTIFIC PROGRAMME
| PROGRAMME AND EXHIBITION GUIDE
MONDAY 2 MAY 2016
Symposium
SBRT FOR OLIGOMETASTATIC DISEASE
08:45 - 10:00 | AUDITORIUM
The use of SBRT for oligometastatic disease is a developing clinical strategy that harnesses our greater
understanding of disease biology and new technology. In this session, we will explore the complex
tumour environment with attention to radiation related immuno-modulating mechanisms, its targets
and abscopal effects. This session will review the current status, definitions and current evidence for the
treatment of oligometastatic disease. Rationale and data will be presented for combination therapies,
evaluating the aggressiveness of SBRT approaches, abdomino-pelvic examplers and the clinical deci-
sion making process.
Chair: V. Khoo (UK)
Co-chair: V. Donato (Italy)
08:45 > Combining SBRT and immunotherapy: a promising approach?
Speaker: F. Herrera (Switzerland)
SP-0405
09:10 > SBRT for metastatic disease: how far can and should we go?
Speaker: M. Dahele (The Netherlands)
SP-0406
09:35 > Abdominal-pelvic targets
Speaker: M. Hoyer (Denmark)
SP-0407
Symposium
HEAD AND NECK: STATE-OF-THE-ART AND DIRECTIONS FOR FUTURE
RESEARCH
08:45 - 10:00 | GIALLA
Chair: J. Bourhis (Switzerland)
Co-chair: E.G. Russi (Italy)
08:45 > Molecular targeting with radiotherapy
Speaker: K. Harrington (UK)
SP-0408
09:10 > Immunotherapy for HNSCC: an emerging paradigm?
Speaker: J. Guigay (France)
SP-0409
09:35 > Proton therapy in HNSCC: better than IMRT?
Speaker: C. Rasch (The Netherlands)
SP-0410